Cardiac Dysfunction Biomarkers Are Associated With Potential for Successful Separation From Extracorporeal Membrane...

Area of Science:

• Biomedical research
• Cardiology
• Pediatric critical care

Background:

• Extracorporeal membrane oxygenation (ECMO) is a life-support measure for critically ill children.
• Identifying biomarkers to guide ECMO weaning is crucial for patient management.
• Cardiac dysfunction assessment is vital during ECMO support.

Purpose of the Study:

• To investigate the association between specific biomarkers and the ability to separate from venoarterial ECMO in pediatric patients.
• To evaluate the utility of Suppression of tumorigenicity 2 (ST2), N-terminal pro-B-type natriuretic peptide (NT-proBNP), galectin-3, and endostatin in predicting ECMO separation.

Main Methods:

• Prospective observational pilot study of 50 pediatric patients (0 to <18 years) on venoarterial ECMO.
• Measurement of plasma ST2, NT-proBNP, galectin-3, and endostatin concentrations at cannulation and during ECMO.
• Comparison of biomarker levels between patients who successfully separated from ECMO and those who could not.

Main Results:

• Higher ST2 concentrations at cannulation were observed in patients unable to separate from ECMO (395.3 ng/mL vs. 207.4 ng/mL, p=0.012).
• ST2 and NT-proBNP levels significantly decreased from the first to the last ECMO day in successfully weaned patients.
• Endostatin levels increased significantly in both groups, while galectin-3 showed no association with ECMO separation.

Conclusions:

• Cardiac dysfunction biomarkers, particularly ST2, may assist in decannulation decisions for pediatric ECMO patients.
• ST2 shows potential as a predictive marker for ECMO separation success.
• Further validation in larger studies is warranted to confirm these findings.